$3.10
+0.13 (+4.38%)
Open$2.95
Previous Close$2.97
Day High$3.10
Day Low$2.95
52W High$468.38
52W Low—
Volume—
Avg Volume55.2K
Market Cap11.33M
P/E Ratio43.82
EPS$1,612.06
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 462.8K | 474.7K | 442.2K |
| Net Income | -17,156 | -18,549 | -17,491 |
| Profit Margin | -3.7% | -3.9% | -4.0% |
| EBITDA | -38,868 | -39,496 | -31,996 |
| Free Cash Flow | -11,585 | -14,526 | -17,935 |
| Rev Growth | +1.4% | -0.9% | -6.2% |
| Debt/Equity | 0.29 | 0.36 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $254.31 | +0.38% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $360.55 | +0.62% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.33 | -1.21% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $499.65 | +1.69% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $631.81 | -0.17% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.52 | +0.74% | 69.3 | 39.97B |